ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score.

Takeshi Hatanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.